RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions
Open Access
- 20 December 2017
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 215 (1) , 319-336
Abstract
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia characterized by granulomatous lesions containing pathological CD207+ dendritic cells (DCs) with constitutively activated mitogen-activated protein kinase (MAPK) pathway signaling. Approximately 60% of LCH patients harbor somatic BRAFV600E mutations localizing to CD207+ DCs within lesions. However, the mechanisms driving BRAFV600E+ LCH cell accumulation in lesions remain unknown. Here we show that sustained extracellular signal–related kinase activity induced by BRAFV600E inhibits C-C motif chemokine receptor 7 (CCR7)–mediated DC migration, trapping DCs in tissue lesions. Additionally, BRAFV600E increases expression of BCL2-like protein 1 (BCL2L1) in DCs, resulting in resistance to apoptosis. Pharmacological MAPK inhibition restores migration and apoptosis potential in a mouse LCH model, as well as in primary human LCH cells. We also demonstrate that MEK inhibitor-loaded nanoparticles have the capacity to concentrate drug delivery to phagocytic cells, significantly reducing off-target toxicity. Collectively, our results indicate that MAPK tightly suppresses DC migration and augments DC survival, rendering DCs in LCH lesions trapped and resistant to cell death.Keywords
Funding Information
- HistioCure Foundation
- National Heart, Lung, and Blood Institute (F31HL126484)
- National Institutes of Health (2R01CA154947-06A1)
- National Institutes of Health (CA154489)
- National Institutes of Health (P50CA126752)
- National Institutes of Health (CA154947, AI10008, AI089987)
- German Research Association (BE 4818/1-1, SFBTRR57 P07)
- St Baldrick’s Foundation
- Alex’s Lemonade Stand Foundation
- American Society of Hematology
- Howard Hughes Medical Institute
- Dan L. Duncan Cancer Center (P30CA125123)
This publication has 61 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Targeting BCL2 Family in Human Myeloid Dendritic Cells: A Challenge to Cure Diseases with Chronic Inflammations Associated with Bone LossJournal of Immunology Research, 2013
- Deciphering the transcriptional network of the dendritic cell lineageNature Immunology, 2012
- GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic CellsImmunity, 2012
- Dendritic Cell and Macrophage Heterogeneity In VivoImmunity, 2011
- GM-CSF–dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunizationJournal of Experimental Medicine, 2010
- Requirement of CCL17 for CCR7- and CXCR4-dependent migration of cutaneous dendritic cellsProceedings of the National Academy of Sciences, 2010
- Autocrine/paracrine TGFβ1 is required for the development of epidermal Langerhans cellsJournal of Experimental Medicine, 2007
- Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleenJournal of Experimental Medicine, 2007
- A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumorsGenes & Development, 2007